Clinical Trial Update: A Study of JNJ-67484703 in Participants With Active Rheumatoid Arthritis [Phase 1]

View source ↗

Summary

A Phase 1 study of JNJ-67484703 in participants with active rheumatoid arthritis has completed (status: COMPLETED).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• JNJ-67484703

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED